Industry reports
Editor highlights

The Outlook for Pharmaceuticals in South East Asia

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 129 pages

BMI View: Singapore is a well-developed pharmaceutical industry, although overall revenues only reached a modest SGD901mn (US Dollar 716mn) in 2011, on account of the small population of the city-state. Nevertheless, the government will continue to prioritise research and biomedical manufacturing, which ...

Industries: Drug and Medication | Countries: Singapore

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • by Global Data
  • February 2014
  • 40 pages

Summary Emcure Pharmaceuticals Ltd. (Emcure) is a pharmaceutical company. The company develops, manufactures and markets health care products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante, Neuroscience, Global HIV, Pharma, Gennova, Oncocare, and APIs. Emcure offers APIs such as acamprosate ...

Industries: Drug and Medication | Countries: India, World, Singapore, South Africa

Agency for Science, Technology and Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agency for Science, Technology and Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • by Global Data
  • February 2014
  • 29 pages

Summary Agency for Science, Technology and Research (A*STAR) is a Singaporean government agency dedicated to fostering world-class scientific research and talent for a vibrant knowledge-based economy. The agency undertakes the research and development activities in biomedical sciences, and physical sciences ...

Industries: Drug and Medication | Countries: Singapore

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2013
  • 130 pages

BMI View: We commend initiatives launched by Singapore's government to ease the financial burden of healthcare on lower-income patients. However, the limited number of hospital beds and disproportionately high private healthcare expenditure will continue to put pressure on patients. BMI believes Singapore's ...

Industries: Drug and Medication | Countries: Singapore

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2013
  • 116 pages

BMI View: Hong Kong continues to be viewed as a moderately attractive longer-term pharmaceutical industry, largely on account of its small overall industry size. While the dominance of patented medicines is set to continue in the medium term, cost-containment pressures will increasingly prioritise the ...

Industries: Drug and Medication | Countries: South Korea, China, Asia, Singapore, United States, Japan, World

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2013
  • 126 pages

BMI View: Singapore is a low risk pharmaceutical industry thanks to political stability and pro-business policies that continue to attract risk adverse investors. Despite high per capita expenditure on healthcare and a developed healthcare system, the small population size will limit long-term industry ...

Industries: Drug and Medication | Countries: Singapore

Singapore Business Projection Industry Update Quarter 4 2011

Singapore Business Projection Industry Update Quarter 4 2011

  • $ 1 208
  • Industry report
  • by Business Monitor International
  • September 2013
  • 47 pages

Core Views Singapore’s real Gross Domestic Product expansion will most likely slow considerably from the 14.5% high registered in 2010, owing to a slowdown in global trade flows as well as the strengthening of the Singapore dollar. These factors should place downward pressure on headline growth, which ...

Industries: Drug and Medication | Countries: Singapore

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • May 2013
  • 122 pages

Includes 3 FREE quarterly updates BMI View: The reduction in healthcare subsidies for permanent residents (PRs) in Singapore, which is to be implemented in two phases over the coming 12 months, is a politically driven move rather than a genuine restructuring of the public healthcare system. The policy ...

Industries: Drug and Medication | Countries: Singapore

Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • by Global Research & Data Services
  • May 2013
  • 1406 pages

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market information for decision-makers including: - Overall market for vaccines in different countries ...

Industries: Drug and Medication | Countries: World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran

Vaccine Market in Singapore

Vaccine Market in Singapore

  • $ 652
  • Industry report
  • by Global Research & Data Services
  • May 2013
  • 19 pages

This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Singapore. The study provides essential market information for decision-makers including: - Overall market for vaccines in Singapore - Market for vaccines by type - Forecasts and ...

Industries: Drug and Medication | Countries: Singapore

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.